Palomar (NASDAQ:PLMR) (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels. The Specialty Program Management segment offers third-party administration, captive insurance solutions and technology-driven services such as claims adjudication, network access and wellness program integration, helping clients manage costs, enhance plan performance and support employee health initiatives.
Headquartered in Chicago, Illinois, Palomar serves a diverse range of mid-market and large employer groups across all 50 states. The company leverages a national distribution network of independent brokers, wholesale agencies and benefits consultants, combined with proprietary data analytics and underwriting platforms, to design and deliver customized solutions that meet the specific risk profiles and financial objectives of its clients.
Since launching operations, Palomar has expanded its capabilities to include cell captive arrangements and pooled coverage programs, reflecting a commitment to innovation in specialty risk financing. The company’s leadership team is composed of seasoned insurance executives with extensive experience in underwriting, claims management and program administration, underscoring Palomar’s focus on disciplined risk selection and service excellence.
